Evidence map›Paper›PMID 35441142›Full record

ArticleRSC chemical biology2022

Structural insights into inhibition of the drug target dihydroorotate dehydrogenase by bacterial hydroxyalkylquinolines.

Samantha M Horwitz, Tamra C Blue, Joseph A Ambarian, Shotaro Hoshino, Mohammad R Seyedsayamdost, Katherine M Davis

Open access · goldAbstract read
In one paragraph

Article in RSC chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Frontiers in microbiology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Samantha M HorwitzDepartment of Chemistry, Emory University Atlanta GA 30322 USA katherine.davis@emory.edu.ORCID https://orcid.org/0000-0002-5407-7674
Tamra C BlueDepartment of Chemistry, Emory University Atlanta GA 30322 USA katherine.davis@emory.edu.
Joseph A AmbarianDepartment of Chemistry, Emory University Atlanta GA 30322 USA katherine.davis@emory.edu.ORCID https://orcid.org/0000-0002-1465-8423
Shotaro HoshinoDepartment of Chemistry, Princeton University Princeton NJ 08544 USA.
Mohammad R SeyedsayamdostDepartment of Chemistry, Princeton University Princeton NJ 08544 USA.ORCID https://orcid.org/0000-0003-2707-4854
Katherine M DavisDepartment of Chemistry, Emory University Atlanta GA 30322 USA katherine.davis@emory.edu.ORCID https://orcid.org/0000-0002-0258-8907
Emory University · USPrinceton University · US

Funding

User Training & OutreachP30GM138396 · NIGMS · UCHICAGO ARGONNE, LLC · PI JANET L. SMITH · 2020 to 2026
$34.3M
High-Speed High-Sensitivity Detector for X-ray Micro-Crystallography at GM/CA@APSS10OD012289 · OD · UNIVERSITY OF CHICAGO · PI FISCHETTI, ROBERT F. · 2014 to 2014
$2.0M
Exploring a New Dimension of Microbial Secondary MetabolismR01GM140034 · NIGMS · PRINCETON UNIVERSITY · PI SEYEDSAYAMDOST, MOHAMMAD R · 2021 to 2024
$1.2M
Learning the Steps to Metalloenzyme ChoreographyR00GM129460 · NIGMS · EMORY UNIVERSITY · PI DAVIS, KATHERINE MARIE · 2020 to 2022
$747k
NIGMS NIH HHS P30 GM138396NIGMS NIH HHS R00 GM129460NIGMS NIH HHS R01 GM140034NIH HHS S10 OD012289
6 · The paper itself

Abstract

Hydroxyalkylquinolines (HAQs) are ubiquitious natural products but their interactions with associated protein targets remain elusive. We report X-ray crystal structures of two HAQs in complex with dihydroorotate dehydrogenase (DHODH). Our results reveal the structural basis of DHODH inhibition by HAQs and open the door to downstream structure-activity relationship studies.

Identifiers

PMID35441142
PMCPMC8984913
OpenAlexW4210704352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.